DaVita (NYSE:DVA) Reaches New 52-Week High – What’s Next?

DaVita Inc. (NYSE:DVA)’s stock price hit a new 52-week high during trading on Thursday . The stock traded as high as $203.54 and last traded at $202.8560, with a volume of 208617 shares traded. The stock had previously closed at $198.54.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on DVA shares. Weiss Ratings restated a “hold (c+)” rating on shares of DaVita in a research note on Monday. Deutsche Bank Aktiengesellschaft upgraded DaVita from a “hold” rating to a “buy” rating and upped their price target for the stock from $126.00 to $220.00 in a research note on Wednesday, May 6th. Truist Financial increased their target price on DaVita from $158.00 to $205.00 and gave the company a “hold” rating in a research note on Friday, May 8th. Barclays increased their target price on DaVita from $158.00 to $194.00 and gave the company an “equal weight” rating in a research note on Thursday, May 7th. Finally, TD Cowen increased their target price on DaVita from $144.00 to $201.00 and gave the company a “hold” rating in a research note on Monday, May 11th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $199.17.

DaVita Trading Up 2.7%

The business has a 50 day simple moving average of $173.98 and a two-hundred day simple moving average of $145.06. The stock has a market cap of $13.08 billion, a price-to-earnings ratio of 18.90, a price-to-earnings-growth ratio of 0.65 and a beta of 0.91.

DaVita (NYSE:DVA) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $2.87 earnings per share for the quarter, beating analysts’ consensus estimates of $2.33 by $0.54. DaVita had a negative return on equity of 270.37% and a net margin of 5.65%.The firm had revenue of $3.42 billion during the quarter, compared to analyst estimates of $3.36 billion. During the same quarter last year, the firm earned $2.00 EPS. DaVita’s quarterly revenue was up 6.0% on a year-over-year basis. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. Research analysts anticipate that DaVita Inc. will post 15.07 EPS for the current fiscal year.

Insider Activity

In related news, CFO Joel Ackerman sold 51,471 shares of the firm’s stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $192.10, for a total value of $9,887,579.10. Following the sale, the chief financial officer owned 132,434 shares of the company’s stock, valued at approximately $25,440,571.40. This trade represents a 27.99% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 1.50% of the company’s stock.

Institutional Trading of DaVita

Several large investors have recently added to or reduced their stakes in the business. Kesler Norman & Wride LLC increased its position in shares of DaVita by 0.8% during the 1st quarter. Kesler Norman & Wride LLC now owns 6,816 shares of the company’s stock valued at $1,048,000 after purchasing an additional 55 shares during the period. Gen Wealth Partners Inc increased its position in shares of DaVita by 10.0% during the 4th quarter. Gen Wealth Partners Inc now owns 880 shares of the company’s stock valued at $100,000 after purchasing an additional 80 shares during the period. NewEdge Advisors LLC increased its position in shares of DaVita by 20.8% during the 1st quarter. NewEdge Advisors LLC now owns 511 shares of the company’s stock valued at $78,000 after purchasing an additional 88 shares during the period. Orion Porfolio Solutions LLC increased its position in shares of DaVita by 4.4% during the 4th quarter. Orion Porfolio Solutions LLC now owns 2,360 shares of the company’s stock valued at $268,000 after purchasing an additional 99 shares during the period. Finally, Root Financial Partners LLC increased its position in shares of DaVita by 128.0% during the 1st quarter. Root Financial Partners LLC now owns 187 shares of the company’s stock valued at $29,000 after purchasing an additional 105 shares during the period. 90.12% of the stock is currently owned by institutional investors and hedge funds.

About DaVita

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.